Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular pathology and prostate cancer therapeutics: from biology to bedside.

The Journal of pathology - 1 Jan 2014

Rodrigues Daniel Nava, Butler Lisa M, Estelles David Lorente, de Bono Johann S

Abstract excerpt

Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men and has an extremely heterogeneous clinical behaviour. The vast majority of PCas are hormonally driven diseases in which androgen signalling plays a central role. The realization that castration-resistant prostate cancer (CRPC) continues to rely on androgen signalling prompted the development of new, effective androgen blocking agents....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to DNA Repair
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Prostatic Neoplasms

Share to Protein Kinase Inhibitors

Share to Translational Research, Biomedical

Share to Tumor Microenvironment

Source

Identifiers

PMID: 24108540
DOI: 10.1002/path.4272

Genes

SPINK1
SPOP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular pathology and prostate cancer therapeutics: from biology to bedside.PMID 24108540Read ↗

Molecular Foundations for Personalized Therapy in Prostate CancerSemantic proximity Read ↗

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic TargetsSemantic proximity Read ↗

Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defectsSemantic proximity Read ↗

The molecular underpinnings of prostate cancer: impacts on management and pathology practiceSemantic proximity Read ↗

The genomic landscape of prostate cancerSemantic proximity Read ↗

The mutational landscape of prostate cancer.Semantic proximity Read ↗

Reprint of: The prostate cancer genome: Perspectives and potential.Semantic proximity Read ↗

The prostate cancer genome: perspectives and potential.Semantic proximity Read ↗

The molecular biology of prostate cancer: current understanding and clinical implications.Semantic proximity Read ↗

Translational and clinical implications of the genetic landscape of prostate cancer.Semantic proximity Read ↗

Molecular therapeutics in prostate cancer.Semantic proximity Read ↗

Molecular landscape of prostate cancer: Implications for current clinical trialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.